ClearPoint Neuro CLPT Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from ClearPoint Neuro’s reported figures.
Based on trailing twelve months.
The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about ClearPoint Neuro's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ClearPoint Neuro's return on equity?
- ClearPoint Neuro (CLPT) reported return on equity of -149.7% in Q1 2026.
- How has ClearPoint Neuro's return on equity changed year-over-year?
- ClearPoint Neuro's return on equity decreased by 96.5% year-over-year, from -76.2% to -149.7%.
- What is the long-term trend for ClearPoint Neuro's return on equity?
- Over 5 years (2020 to 2025), ClearPoint Neuro's return on equity has grown at a -13.3% compound annual growth rate (CAGR), from -194.8% to -95.6%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.